| Brooke Elizabeth Ballard, | |
|
1015 Oakhurst Dr, Charleston, WV 25314-2049 | |
| (304) 345-8101 | |
| (304) 345-7386 |
| Full Name | Brooke Elizabeth Ballard |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1015 Oakhurst Dr, Charleston, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720372402 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | SLP0717 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brooke Elizabeth Ballard, 1015 Oakhurst Dr, Charleston, WV 25314-2049 Ph: (304) 345-8101 | Brooke Elizabeth Ballard, 1015 Oakhurst Dr, Charleston, WV 25314-2049 Ph: (304) 345-8101 |
News Archive
Though President Barack Obama did not say exactly how screening procedures would change, the director of the Centers for Disease Control and Prevention said officials would consider a variety of options.
EXASOL, a high-performance in-memory analytic database developer, and PATH, an international nonprofit organization and global leader in health and innovation, today announced a partnership to support the Zambian government's ambitious campaign to eliminate malaria by 2020.
Medicago, a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that the last dose of vaccine has been administered completing the first part of the Company's Phase II human clinical trial with its H5N1 Avian Influenza vaccine.
Stroke patients who were older and had disturbances of their consciousness had a greater risk of death in the hospital following thrombolytic (clot-dissolving) therapy, according to an article in the October 20 JAMA.
Quantifying tablet disintegration profiles in situ and in real time enables scientists to reliably understand the breakage and dispersion mechanisms that govern API release rates. This essential process knowledge can support the prediction of in vivo drug release profiles during formulation development, and help identify the root cause of inconsistencies during release testing.
› Verified 6 days ago
Vicki Horn, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 | |
Rebecca Kelley, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7770 | |
Hannah Chinn, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 300 Baker Ln, Charleston, WV 25302 Phone: 304-346-2323 | |
Ericka Brown, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 Elizabeth St, Charleston, WV 25311 Phone: 304-348-7740 Fax: 304-348-6671 | |
Tiffany N Evans, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1026 Gordon Dr, Charleston, WV 25303 Phone: 304-421-0854 | |
Michelle Renee Robinson, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 125 Wertz Ave, Charleston, WV 25311 Phone: 304-610-7171 | |
Ms. Amanda S Casto, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1000 Lincoln Drive, Charleston, WV 25309 Phone: 304-768-4400 |